GlassScriptPhysician profile
Keeley M Pollman
NPI 1902993447
$822.63
in general payments reported to CMS, 2019-2025
19 companies · $232 in 2025
The $232 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $254 · 2023: $225 · 2024: $111 · 2025: $232.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $568.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $568.26 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $180.52 | 2022-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Hologic Sales and Service, LLC | $96.55 | 2023-2025 | Coolseal Generator, Sonata Sonography-Guided Transcervical Fibroid Ablation System, Acessa Provu System |
| Medtronic, INC. | $80.34 | 2022-2025 | Signia, Sonicision, Ligasure |
| Takeda Pharmaceuticals U.S.A., INC. | $57.10 | 2022-2023 | Gattex |
| Histosonics, INC. | $50.15 | 2025 | |
| Solventum Corporation | $47.14 | 2024-2025 | Prevena, V.A.C.Ulta, Abthera Advance |
| Enterra Medical, INC. | $46.42 | 2022 | |
| Organogenesis INC. | $37.92 | 2022-2023 | Puraply |
| Kci USA, INC. | $29.66 | 2022-2023 | Prevena, V.A.C. Dermatac, V.A.C. Veraflo |
| Abbvie INC. | $28.04 | 2023 | |
| Tela Bio, INC. | $26.53 | 2023 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex) |
| Acacia Pharma INC | $24.48 | 2022 | |
| Innovation Technologies INC | $22.38 | 2022 | |
| Csl Behring | $20.73 | 2022 | |
| Seagen INC. | $16.74 | 2023 | Tivdak |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $15.92 | 2024 | Spyglass Discover |
| Ethicon US, LLC | $15.50 | 2023 | Ethicon, Vistaseal |
| Organon LLC | $14.73 | 2025 | Nexplanon |
| Kerecis Limited | $11.78 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Keeley Pollman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.